| First Author | Afonso MB | Year | 2018 |
| Journal | Cell Death Differ | Volume | 25 |
| Issue | 5 | Pages | 857-872 |
| PubMed ID | 29229992 | Mgi Jnum | J:303000 |
| Mgi Id | MGI:6510105 | Doi | 10.1038/s41418-017-0019-x |
| Citation | Afonso MB, et al. (2018) miRNA-21 ablation protects against liver injury and necroptosis in cholestasis. Cell Death Differ 25(5):857-872 |
| abstractText | Inhibition of microRNA-21 (miR-21) prevents necroptosis in the mouse pancreas. Necroptosis contributes to hepatic necro-inflammation in the common bile duct ligation (BDL) murine model. We aimed to evaluate the role of miR-21 in mediating deleterious processes associated with cholestasis. Mechanistic studies established a functional link between miR-21 and necroptosis through cyclin-dependent kinase 2-associated protein 1 (CDK2AP1). miR-21 expression increased in the liver of primary biliary cholangitis (PBC) patients and BDL wild-type (WT) mice at both 3 and 14 days. Notably, under BDL, miR-21 (-/-) mice displayed decreased liver injury markers in serum compared with WT mice, accompanied by reduced hepatocellular degeneration, oxidative stress and fibrosis. Hallmarks of necroptosis were decreased in the liver of BDL miR-21 (-/-) mice, via relieved repression of CDK2AP1. Further, miR-21 (-/-) mice displayed improved adaptive response of bile acid homeostasis. In conclusion, miR-21 ablation ameliorates liver damage and necroptosis in BDL mice. Inhibition of miR-21 should arise as a promising approach to treat cholestasis. |
